Cairo Pharmaceuticals (CPCI.CA) - Report of the Central Auditing Organization
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Report of the Central Auditing Organization on the financial statements for the financial period ending on 31/12/2023.
The Report of the Central Auditing Organization (3,072 KB)
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Report of the Central Auditing Organization on the financial statements for the financial period ending on 31/12/2023.
The Report of the Central Auditing Organization (3,072 KB)
Comments